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consumption to find any significant difference.METHODS:A total of 161 antibiotics
are in Iran’s drugs list. According to Iran’s FDO regulations all pharmaceutical
companies should report their sales statistics to this organization each month.
Sales amount could be derived from this database state by state. According toWHO
method, each drug ATC and DDD code have been derived. DID index (Defined daily
dose /1000 Inhabitants/ Day) have been calculated according to the population of
each states. RESULTS: Correlation coefficients of ascending trends of antibiotics in
Northern states’ and Iran have been reported respectively as following: In oral
antibiotics, four classes have significant ascending trend: Betalactams (0.715 vs.
0.693), Cephalosporines (0.99 vs. 0.989), Macrolides (0.911 vs. 0.949), Quinolones
(0.897 vs. 0.9). Three classes have significant descending trend: Amphenicoles
(-0.836 vs. -0.76), Sulfonamides (- 0.924 vs. -0.948), Aminoglycosides (-0.809 vs.
-0.943). In parenteral antibiotics two classes have significant ascending trend: Imi-
penem (0.967 vs. 0.979), Macrolides (0.951 vs. 0.95). Two of them have significant
descending trend: Betalactams (- 0.916 vs. -0.79), Aminoglycosides (-0.809 vs.
-0.943). CONCLUSIONS: Most trends were ascending and same as the pattern of
whole countries consumption. These results approve the theory of the priority in
training programs to clinicians and people according to RUD’s goals in Northern
states’ same as other parts of country.
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OBJECTIVES: Considering diabetes as a major public health problem worldwide,
the aim of our study was to analyze overall volume of use of antidiabetics, com-
pared to Croatia, as the neighboring country, and Denmark, chosen for its rational
and conservative prescription practice. METHODS: Data for consumption of anti-
hyperglycaemic drugs (A10) in 2010 were obtained by a retrospective, observa-
tional, population-based study. Utilization of these drugs was expressed as DDD
per 1000 inhabitants a day (DID). RESULTS: In 2010, antidiabetics (A10) were used at
a similar rate in Serbia, Croatia and Denmark (47.34 DID, 49.88 DID and 47.50 DID,
respectively), but the share of utilization of insulins (A10A) and oral antidiabetics
(A10B) differed between countries. Relatively high proportion of insulin use in Den-
mark (36.2% of all antidiabetics) compared to Serbia (22.0%) and Croatia (26.4%)
may be attributed to high incidence of type 1 diabetes in Nordic countries and
compliance with most of recent pharmacotherapeutic guidelines that suggest the
use of long-acting insulins (A10AE) in type 2 diabetes (4.0 DID of A10AE inDenmark,
in comparison to 1.28 DID in Serbia and 1.91 DID in Croatia). Proportions of oral
antidiabetics use also differed between these countries. Metformin, as the only
biguanide (A10BA) used and preferred oral agent for type 2 diabetes, accounted for
51.2% of total use of oral antidiabetics in 2010 in Denmark, while sulfonylureas
(A10BB), as a second-line treatment, were used at a rate of 36.6%. In Serbia and
Croatia, sulfonylureas were used predominantly (55.6% and 48.6, respectively).
New medicinal products with effect on the incretin system (A10BH and A10BX)
were used at a rate of 4.1 DID in Denmark, contrary to 0.45 DID in Croatia and 0.002
DID in Serbia. CONCLUSIONS: The large differences in utilization of various an-
tidiabetics between observed countries suggest considerable variations in habits,
especially with regard to type 2 diabetes treatment.
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OBJECTIVES: To explore the effect of retirement on retiree’s mental health, this
study investigated the change in the usage of sedative-hypnotic drugs after the
retirement for sedative-hypnotic users. METHODS: We conducted a retrospective
cohort study with comparison groups through following a population-based ran-
dom sample containing one-million beneficiaries of Taiwan’s National Health In-
surance from 1999 to 2009. Individuals retired between 2000 and 2003 and aged
between 50 and 64 were first identified. Those taking sedative-hypnotic drugs at
least one year before and six years after retirement were selected as the study
sample, and were further stratified into high-dosage and low-dosage users based
on their defined daily doses (DDDs). A propensity score (PS) matching was con-
ducted to select two non-retiree control groups with respect to sedative-hypnotic
dosage. Each non-retiree was assigned a pseudo retirement date, the same retire-
ment date as his/her matching retiree counterpart. Nonparametric Wilcoxon tests
were conducted to compare the differences in DDDs between the retiree and con-
trol groups. Generalized estimating equations (GEE) were employed to investigate
the odds ratios (ORs) of drug usage between the retiree and control groups.
RESULTS: 9,687 retired sedative-hypnotic users were identified. After PSmatching,
the number of high-dosage users in both retiree and control groups was 3,265, and
the number of low-dosage users was 3,072. The Wilcoxon tests revealed no differ-
ence in DDDs between the retirees and non-retirees before and after their retire-
ments. The GEE analyses however showed that, compared to their non-retiree
counterparts, the low-dosage retired users significantly reduced the dosage of after
their retirement (OR0.97, p  0.05). A similar trend was observed in the high-
dosage users but no significance. CONCLUSIONS: The decrease in the dependence
on sedative-hypnotic drugs after their retirements for low-dosage usersmight sug-
gest the retirement had a positive influence on mental health.
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OBJECTIVES: To systematically identify the main factors those contribute towards
the increase of pharmaceutical expenditures. METHODS: A systematic search of
published studies was conducted in common major electronic databases using
search terms “factors’’, ‘‘financing ’’, ‘‘pharmaceutical’’, and ‘‘expenditures’’. To be
included the studies need to 1) measure at least one of the following outcomes:
total growth in pharmaceutical expenditures, price growth quantity growth; 2) A
clear method to analyze the impact of factors affecting the increases of drug ex-
penditures was mentioned; 3) were written in English. Non-primary articles that
were published only as abstract, review; commentary and letter were excluded.
Data were extracted from the primary eligible studies using data abstraction form.
Information regarding study title, study author (s), country, year, study objective,
study design, statisticalmethods to assess factors affecting pharmaceutical expen-
ditures, results, and author (s) conclusionswere collected.RESULTS: Froma total of
2039 studies, only 20 studies were included for full review. The most significant
determinants or factors of drug spending are demographic, disease category, pub-
lic health, price, utilization, therapeutic choice, and residual –productmix. A num-
ber of studies from the review indicate that residual –product mix responsible for
between approximately 30 per cent to approximately 493 per cent of total increases
drug expenditures. CONCLUSIONS: Price change has little effect on expenditure
increases compared with utilization and the residual. All the above factors need to
be considered for optimum drug policy design. It is most important for policy
makers to understand pharmaceutical spending trends, the factor influencing the
rising of the limited resources and the main cost containment strategies.
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OBJECTIVES:Depressive disorder is one of themajor public health problems due to
significant disability that it causes, aswell difficulties in diagnostic procedures. The
aim of the study was to determine the total antidepressant utilization in Serbia in
correlation with Denmark and to get insight into financial resources allocations.
Denmark was chosen for its developed pharmacotherapeutic practice.METHODS:
Data for antidepressant (ATC group N06) utilization and consumption of financial
resources in 2010 were retrieved from the annual reports of relevent public insti-
tutions. The ATC/DDD methodology was applied and results were expressed in
defined daily doses (DDDs) per 1000 inhabitants per day (DID). RESULTS: An inter-
esting result of our study is that the utilization of antidepressants in 2010 appeared
to be 7-fold higher in Denmark (83.8 DID) than in our country (11.67 DID). In accor-
dancewith these results, the consumption of financial resources for groupN06was
approximately 9-fold higher inDenmark (89.680.072USD) than in Serbia (10.261.963
USD). The most commonly used group of antidepressants in both countries were
selective serotonine reuptake inhibitors (SSRI) (67.3% and 73.76% of all antidepres-
sants for Denmark and Serbia respectively) which complies with the most recent
clinical guidelines. There was a considerable difference between Denmark and
Serbia in the utilization of a group N06AX which includes new generation of anti-
depressants (22.7 DID and 1.39 DID respectively). CONCLUSIONS: The differences
between selected countries in antidepressant utilization and consumption of fi-
nancial resources are partly consequential to different socioeconomic and health
policy factors. This study shows that the overall utilization of antidepressants in
Serbia is lower than in Denmark, which implies possible underdiagnosing of affec-
tive disorders in general practice.
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OBJECTIVES: To analyze the current utilization and expenditure of reimbursed
digestive enzyme agents (DEs) in Taiwan. METHODS: The encrypted claim data-
base of National Health Insurance (NHI) was used to analyze the prescription pat-
terns and the expenditure of DEs for types of diseases, health care specialties,
levels of medical institution, and insured BNHI branch. RESULTS: We identified
that 29DEs,within 15 groupings, are reimbursed byNHI up to 2011. Given thatmost
DEs were developed in earlier stage, while only 2 items were approved by the
Taiwan Food and Drug Administration after 2000, these approved items had
broader scope of approved indications and limited evidence on their clinical effi-
cacy. According to the analysis of 2001-2010 NHI databases, the most enzymes
prescribed disease was gastroenteritis, related uncomfortable symptoms, and so
forth. Over the ten years, the number of medical orders increased from 22.77 mil-
lion to 46.71 million. Medical costs increased from more than NT$ 1 hundred mil-
lion to over NT$ 2 hundred million. The highest usage rate of medical orders, by
specialties, is 64% in Internal Medicine, especially in Gastroenterology and in Gen-
eral Medicine. The second is 7% to 9.6 % in Family Medicine. The usage rate is
increasing each year in Surgery, from 4.13% in 2011 to 9.27% in 2010. The usage
rates of medical order by 15 groupings have various trends of levels between dif-
ferent medical institution, and different insured BNHI branch. CONCLUSIONS:
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Some countries’ pharmaceutical benefits programs such as Australia, Canada, or
U.S. listed DEs for pancreatic insufficiency due to chronic pancreatitis, carcinoma
of the pancreas, or cystic fibrosis, however, those reimbursed by Taiwan NHI had
broader scope of indications. In addition to more medical orders prescribed by
varied health care specialties, we observed the expenditure increased by approxi-
mately two times over the past 10 years.
PHP31
KNOWLEDGE AND PRACTICE OF DISPOSAL OF DATE EXPIRED AND UNUSED
DRUGS
Muragundi PM1, Priyendu A1, Janodia M1, Ligade VS1, Udupa N2, Naik AN2
1Manipal University, Manipal, India, 2Manipal College of Pharmaceutical Sciences, Manipal,
Karnataka, India
OBJECTIVES:Knowledge and practice of disposal of date expired and unused drugs
among college students and people having a health science background and to find
the most widely used method of drug disposal for the expired drugs in the study
group.METHODS:Apilot study questionnairewas prepared and a surveywas done
among students with Health Science background to understand the appropriate-
ness of content. Further 500University students andpeople having ahealth science
background were interviewed personally using the validated questionnaire pre-
pared. Results were presented percentage responses and interpretation of the re-
sults helped in the derivation of the final conclusion. RESULTS:When asked about
the awareness of the existing guidelines for the safe disposal of drugs in various
countries 56% of the respondents knew about it while 44%were unaware. A total of
52.2% of the respondents agreed that the wrong drug disposal methods can lead to
adverse environmental effects while 25.6% strongly agreed to it. A mere 4.8% dis-
agreed to the statementwhile another 17.4% somewhat agreed to it; 56.8% strongly
agreed to the fact that there was a need of a drug take back system in their place of
residence. A total of 57.2% opined that there was a need of public awareness pro-
grams to increase the awareness about drug disposal in the general public. A ma-
jority 91.2% of the respondents admitted that they simply throw the expired drugs
into the dustbins. 46.8% of the people said there was no work being done in this
context by any organization. CONCLUSIONS: The study clearly indicates lack of
awareness and good practices of date expired drugs among surveyed population.
There is a need to create awareness regarding disposal of drugs among the popu-
lation which should be done either by the government or any organization.
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OBJECTIVES: Adequate use of antimicrobial agent is critical issue in hospital. It
would enlarge the burden, for instance increase medical expenditure and antimi-
crobial resistance rate, if misuse. To evaluate the annual use of the third line
antibiotic agents - fluoroquinolones, including ciprofloxacin, moxifloxacin and
levofloxain, and that could be took a reference to manage the use in a regional
teaching hospital.METHODS: The data, including patient-days and the consump-
tion quantity of ciprofloxacin, moxifloxacin and levofloxain, was extracted
monthly from Hospital Information System of a regional teaching hospital from
January 2010 to December 2011. Consumption quantity was transferred to
“1000DDD /patient-days”. Data management and analysis was performed using
student t test. RESULTS:Number of 1000DDD /patient-days in all fluoroquinolones
were 202.47 in 2010, 202.47 in 2022 and there was no significantly difference
(p0.067). Number of 1000DDD /patient-days in ciprofloxacin significantly de-
creased (p 0.0023) in 2011(1000DDD /patient-days 127.35) comparing with 2010
does (1000DDD /patient-days 181.69). Number of 1000DDD /patient-days inmoxi-
floxacin were 38.95 in 2010 and 48.08 in 2011. In the aspect of levofloxacin, number
of 1000DDDwere 25.46 in 2010 and 27.03 in 2011. The number of 1000DDD /patient-
days in Moxifloxacin and levofloxacin both were no significantly difference be-
tween 2011 and 2010. CONCLUSIONS: The fluoroquinolones consumption de-
creased especially on ciprofloxacin, but the levofloxacin and moxifloxacin mild
increased. Although no significantly difference on the amount of all fluoroquino-
lones between 2010 and 2011may be good and stand for well control. But extenting
the study to the outcomes of infection control and the association of the culture
results would be more objective.
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OBJECTIVES: To identify the nature and frequency of DRPs (drug interaction and
irrational dose), and their impacts on length of stay (LOS) of patients with chronic
kidney disease (CKD) stage 4 and 5 hospitalized in Haji AdamMalik (HAM) Hospital,
Indonesia. METHODS: This retrospective cohort study was conducted on 80 pa-
tients based on JAMKESMAS database for 6-month period (October 2009 - March
2010). Inclusion criteria were patients administered antibiotics and GFR of 30
mL/min/1.73 m2. Exclusion criteria were patients under 18 years old, patients with
cancer, and patient with Human Immunodeficiency Virus (HIV). Data collected
include type of drugs administered, laboratory tests, and clinical outcomes. Iden-
tification of drug interaction and analysis of antibiotics dose rationality were per-
formed using Stockley’s drug interactions, Medlines, and Handbook of Clinical
Drug Data. The impacts of DRPs on LOS were performed by multiple linear regres-
sion analysis. RESULTS: Of the sample, male was 66% and female was 34%; CKD
stage 4 was 17% and CKD stage 5 was 83%. Most drug interactions were between
NSAIDs and ACE inhibitor, ranitidine and furosemide, ranitidine and ciprofloxacin,
metoclopramide and NSAIDs, dexamethasone and furosemide, NSAIDs and furo-
semide.Mean value of drug interactionwas 1 1.31.Most frequent irrational doses
of antibiotics involved ceftriaxone, ceftazidime, cefadroxyl, ciprofloxacin, and
amoxicillin. Mean value of irrational doses was 0.43  0.67. Means of LOS was
6.645.76.Multiple linear equation obtained: y 3.91 2.16x1 0.97x2; y LOS; x1
 drug interaction; x2 irrational dose of antibiotics. CONCLUSIONS: This finding
must be highlighted and considered to optimize treatment of CKD. Impact of drug
interaction on LOS of CKD patients was higher compared to that of irrational dose
of antibiotics.
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OBJECTIVES: Although most of the medications containing herbal extracts have
been used in the treatment of diseases for many years, the evidence on the clinical
efficacy and safety are still in controversy. It is necessary to conduct an evaluation
on these products.METHODS: First, we defined the medications containing herbal
extracts in this study, aswell as identified the items reimbursed inNational Health
Insurance. In the next step, we analyzed the 2001-2007 National Health Insurance
Research Database (NHIRD) to find themost frequently used items in the category.
Silymarin was identified as the most used during 2001-2007. We conducted the
literature search and review on the clinical effectiveness of the ingridient.
RESULTS: In this review, we summarized the reports published by the literature.
These reports had systematically reviewed on the topic of the effectiveness of
silymarin in patients with alcoholic and /or hepatitis B or C liver diseases. In the
report by The Cochrane Collaboration - a total of thirteen randomized trials as-
sessed silymarin in patients with alcoholic and /or hepatitis B or C liver diseases
were included in the meta-analysis. Results from these trials showed a significant
effect of silymarin on liver-related mortality (RR 0.50, 95% CI 0.29 - 0.88), but no
significant effects could be demonstrated if the analysis were restricted on only
high quality trials (RR 0.57, 95% CI 0.28 - 1.19). For the resource utilization of sily-
marin, we found that the total claims on silymarin increased 59.83% fromyear 2001
to 2007. CONCLUSIONS: As mentioned above, the effectiveness of silymarin in
patients with liver disease has not been established. Further studies on mecha-
nisms of action, as well as related well-designed clinical trials are needed.
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OBJECTIVES: To quantify the association between disability and prescriptionmed-
ication use among older adults. Individuals with disability may consume more or
varying types of prescription medication, thereby requiring special services.
METHODS: Data from the nationally-representative Health and Retirement Study
2006 and the Prescription Drug Study 2007 in the United States were used to exam-
ine associations between disability and prescription medication use among 2,755
adults. The dependent variable, disability versus no disability, was determined
based on responses to questions assessing functional, mobility, and cognitive sta-
tus. Subjects responding affirmatively to one of these types of disabilities were
classified as disabled. Chi-square tests assessed the dependent categorical vari-
ables by disability. Negative binomial regressions were used to examine the rela-
tionship between disability and prescriptionmedication use, controlling for acces-
sibility, affordability, beliefs in medication, health conditions and socio-
demographic variables. RESULTS: Of the 2,755 subjects, 70.8% were classified as
disabled. Female, older, non-white, widowed, less educated, living in rural area,
lower income, having three chronic diseases, poor health status, no alcohol or
smoking habits, hardly exercise, taking prescription drugs regularly, and consult-
ing with medical doctors more were all statistically significant variables indicative
of greater risk of disability (P0.0001). Subjects classified as disabled [IRR1.09 (95%
CI, 1.03-1.15)], with three or more chronic conditions [IRR2.08 (95% CI, 1.93-2.35)],
not exercising [IRR1.08 (95% CI, 1.04-1.10)], taking medications regularly
[IRR1.85 (95% CI, 1.51-2.27)] and sevenmore times doctor visits [IRR1.46 (95% CI,
1.36-1.57)] had a greater incidence of prescription medication uses. Subjects with
lower income [IRR0.99 (95% CI, 0.99-0.99)], no alcohol or smoking habits [IRR0.93
(95% CI, 0.88-0.98)] had a lower incidence likelihood of prescription medication
uses. CONCLUSIONS:Disability was a statistically significant predictor of prescrip-
tion medication use. Further research is necessary to examine the associations
between specific disability types and medications use.
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OBJECTIVES: Compare oral 5-aminosalicylic acid (5-ASA) treatment persistence
and adherence in patients with mild/moderate ulcerative colitis (UC). METHODS:
IMS LifeLink™Health Plan claims datawere analyzed to identify patients18 years
with 1 UC diagnosis (ICD-9-CM: 556.x) and had 1 prescription for 5-ASA (sul-
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